IBDEI34I ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49885,1,3,0)
;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
;;^UTILITY(U,$J,358.3,49885,1,4,0)
;;=4^I82.409
;;^UTILITY(U,$J,358.3,49885,2)
;;=^5133625
;;^UTILITY(U,$J,358.3,49886,0)
;;=I82.509^^193^2485^27
;;^UTILITY(U,$J,358.3,49886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49886,1,3,0)
;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
;;^UTILITY(U,$J,358.3,49886,1,4,0)
;;=4^I82.509
;;^UTILITY(U,$J,358.3,49886,2)
;;=^5133628
;;^UTILITY(U,$J,358.3,49887,0)
;;=E78.1^^193^2486^23
;;^UTILITY(U,$J,358.3,49887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49887,1,3,0)
;;=3^Pure Hyperglyceridemia
;;^UTILITY(U,$J,358.3,49887,1,4,0)
;;=4^E78.1
;;^UTILITY(U,$J,358.3,49887,2)
;;=^101303
;;^UTILITY(U,$J,358.3,49888,0)
;;=E78.2^^193^2486^21
;;^UTILITY(U,$J,358.3,49888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49888,1,3,0)
;;=3^Mixed Hyperlipidemia
;;^UTILITY(U,$J,358.3,49888,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,49888,2)
;;=^78424
;;^UTILITY(U,$J,358.3,49889,0)
;;=I10.^^193^2486^9
;;^UTILITY(U,$J,358.3,49889,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49889,1,3,0)
;;=3^Essential Primary Hypertension
;;^UTILITY(U,$J,358.3,49889,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,49889,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,49890,0)
;;=I11.9^^193^2486^19
;;^UTILITY(U,$J,358.3,49890,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49890,1,3,0)
;;=3^Hypertensive Heart Disease w/o Heart Failure
;;^UTILITY(U,$J,358.3,49890,1,4,0)
;;=4^I11.9
;;^UTILITY(U,$J,358.3,49890,2)
;;=^5007064
;;^UTILITY(U,$J,358.3,49891,0)
;;=I11.0^^193^2486^18
;;^UTILITY(U,$J,358.3,49891,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49891,1,3,0)
;;=3^Hypertensive Heart Disease w/ Heart Failure
;;^UTILITY(U,$J,358.3,49891,1,4,0)
;;=4^I11.0
;;^UTILITY(U,$J,358.3,49891,2)
;;=^5007063
;;^UTILITY(U,$J,358.3,49892,0)
;;=I12.0^^193^2486^15
;;^UTILITY(U,$J,358.3,49892,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49892,1,3,0)
;;=3^Hypertensive Chr Kidney Disease w/ ESRD
;;^UTILITY(U,$J,358.3,49892,1,4,0)
;;=4^I12.0
;;^UTILITY(U,$J,358.3,49892,2)
;;=^5007065
;;^UTILITY(U,$J,358.3,49893,0)
;;=I13.10^^193^2486^13
;;^UTILITY(U,$J,358.3,49893,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49893,1,3,0)
;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,49893,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,49893,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,49894,0)
;;=I13.0^^193^2486^11
;;^UTILITY(U,$J,358.3,49894,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49894,1,3,0)
;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,49894,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,49894,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,49895,0)
;;=I13.11^^193^2486^14
;;^UTILITY(U,$J,358.3,49895,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49895,1,3,0)
;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
;;^UTILITY(U,$J,358.3,49895,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,49895,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,49896,0)
;;=I13.2^^193^2486^12
;;^UTILITY(U,$J,358.3,49896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49896,1,3,0)
;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
;;^UTILITY(U,$J,358.3,49896,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,49896,2)
;;=^5007070
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34I 3757 printed Sep 23, 2025@20:17:40 Page 2
IBDEI34I ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49885,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,49885,1,3,0)
+4 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
+5 ;;^UTILITY(U,$J,358.3,49885,1,4,0)
+6 ;;=4^I82.409
+7 ;;^UTILITY(U,$J,358.3,49885,2)
+8 ;;=^5133625
+9 ;;^UTILITY(U,$J,358.3,49886,0)
+10 ;;=I82.509^^193^2485^27
+11 ;;^UTILITY(U,$J,358.3,49886,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,49886,1,3,0)
+14 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
+15 ;;^UTILITY(U,$J,358.3,49886,1,4,0)
+16 ;;=4^I82.509
+17 ;;^UTILITY(U,$J,358.3,49886,2)
+18 ;;=^5133628
+19 ;;^UTILITY(U,$J,358.3,49887,0)
+20 ;;=E78.1^^193^2486^23
+21 ;;^UTILITY(U,$J,358.3,49887,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,49887,1,3,0)
+24 ;;=3^Pure Hyperglyceridemia
+25 ;;^UTILITY(U,$J,358.3,49887,1,4,0)
+26 ;;=4^E78.1
+27 ;;^UTILITY(U,$J,358.3,49887,2)
+28 ;;=^101303
+29 ;;^UTILITY(U,$J,358.3,49888,0)
+30 ;;=E78.2^^193^2486^21
+31 ;;^UTILITY(U,$J,358.3,49888,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,49888,1,3,0)
+34 ;;=3^Mixed Hyperlipidemia
+35 ;;^UTILITY(U,$J,358.3,49888,1,4,0)
+36 ;;=4^E78.2
+37 ;;^UTILITY(U,$J,358.3,49888,2)
+38 ;;=^78424
+39 ;;^UTILITY(U,$J,358.3,49889,0)
+40 ;;=I10.^^193^2486^9
+41 ;;^UTILITY(U,$J,358.3,49889,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,49889,1,3,0)
+44 ;;=3^Essential Primary Hypertension
+45 ;;^UTILITY(U,$J,358.3,49889,1,4,0)
+46 ;;=4^I10.
+47 ;;^UTILITY(U,$J,358.3,49889,2)
+48 ;;=^5007062
+49 ;;^UTILITY(U,$J,358.3,49890,0)
+50 ;;=I11.9^^193^2486^19
+51 ;;^UTILITY(U,$J,358.3,49890,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,49890,1,3,0)
+54 ;;=3^Hypertensive Heart Disease w/o Heart Failure
+55 ;;^UTILITY(U,$J,358.3,49890,1,4,0)
+56 ;;=4^I11.9
+57 ;;^UTILITY(U,$J,358.3,49890,2)
+58 ;;=^5007064
+59 ;;^UTILITY(U,$J,358.3,49891,0)
+60 ;;=I11.0^^193^2486^18
+61 ;;^UTILITY(U,$J,358.3,49891,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,49891,1,3,0)
+64 ;;=3^Hypertensive Heart Disease w/ Heart Failure
+65 ;;^UTILITY(U,$J,358.3,49891,1,4,0)
+66 ;;=4^I11.0
+67 ;;^UTILITY(U,$J,358.3,49891,2)
+68 ;;=^5007063
+69 ;;^UTILITY(U,$J,358.3,49892,0)
+70 ;;=I12.0^^193^2486^15
+71 ;;^UTILITY(U,$J,358.3,49892,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,49892,1,3,0)
+74 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
+75 ;;^UTILITY(U,$J,358.3,49892,1,4,0)
+76 ;;=4^I12.0
+77 ;;^UTILITY(U,$J,358.3,49892,2)
+78 ;;=^5007065
+79 ;;^UTILITY(U,$J,358.3,49893,0)
+80 ;;=I13.10^^193^2486^13
+81 ;;^UTILITY(U,$J,358.3,49893,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,49893,1,3,0)
+84 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
+85 ;;^UTILITY(U,$J,358.3,49893,1,4,0)
+86 ;;=4^I13.10
+87 ;;^UTILITY(U,$J,358.3,49893,2)
+88 ;;=^5007068
+89 ;;^UTILITY(U,$J,358.3,49894,0)
+90 ;;=I13.0^^193^2486^11
+91 ;;^UTILITY(U,$J,358.3,49894,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,49894,1,3,0)
+94 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
+95 ;;^UTILITY(U,$J,358.3,49894,1,4,0)
+96 ;;=4^I13.0
+97 ;;^UTILITY(U,$J,358.3,49894,2)
+98 ;;=^5007067
+99 ;;^UTILITY(U,$J,358.3,49895,0)
+100 ;;=I13.11^^193^2486^14
+101 ;;^UTILITY(U,$J,358.3,49895,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,49895,1,3,0)
+104 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
+105 ;;^UTILITY(U,$J,358.3,49895,1,4,0)
+106 ;;=4^I13.11
+107 ;;^UTILITY(U,$J,358.3,49895,2)
+108 ;;=^5007069
+109 ;;^UTILITY(U,$J,358.3,49896,0)
+110 ;;=I13.2^^193^2486^12
+111 ;;^UTILITY(U,$J,358.3,49896,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,49896,1,3,0)
+114 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
+115 ;;^UTILITY(U,$J,358.3,49896,1,4,0)
+116 ;;=4^I13.2
+117 ;;^UTILITY(U,$J,358.3,49896,2)
+118 ;;=^5007070
